Seeking Alpha

Shares of Threshold Pharmaceuticals (THLD) gain 5.5% in premarket trading after Lazard Capital...

Shares of Threshold Pharmaceuticals (THLD) gain 5.5% in premarket trading after Lazard Capital lifts its price target to a high-flying $15 after digesting the firm's good results from a trial of its pancreatic cancer drug candidate.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)